AstraZeneca neither confirms nor denies that it will ditch antibiotics research
The fight against antibiotic-resistant microbes could suffer a major blow if widely circulated rumours are confirmed that pharmaceutical giant AstraZeneca is due to disband its in-house antibiotic development. The company called the rumours “highly speculative”, while not explicitly denying them. Read more
Recent comments on this blog
Experiments reveal that crabs and lobsters feel pain
US research ethics agency upholds decision on informed consent
Chemistry credit disputes under the spotlight
Chemistry credit disputes under the spotlight
Contamination created controversial ‘acid-induced’ stem cells